MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 9.720
AS - Asia 4.630
EU - Europa 2.200
SA - Sud America 696
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 84
OC - Oceania 16
Totale 17.454
Nazione #
US - Stati Uniti d'America 9.534
SG - Singapore 1.717
CN - Cina 1.214
BR - Brasile 551
UA - Ucraina 520
VN - Vietnam 463
HK - Hong Kong 413
DE - Germania 366
TR - Turchia 358
GB - Regno Unito 297
IT - Italia 185
PL - Polonia 163
FR - Francia 162
FI - Finlandia 151
SE - Svezia 124
RU - Federazione Russa 94
JP - Giappone 92
MX - Messico 83
IN - India 77
CA - Canada 70
BD - Bangladesh 56
AR - Argentina 45
ZA - Sudafrica 39
ID - Indonesia 38
BE - Belgio 34
IQ - Iraq 34
CO - Colombia 30
NL - Olanda 26
PK - Pakistan 25
ES - Italia 23
CL - Cile 20
UZ - Uzbekistan 17
EC - Ecuador 16
AU - Australia 14
MY - Malesia 14
VE - Venezuela 14
PH - Filippine 13
SA - Arabia Saudita 13
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
IR - Iran 10
LT - Lituania 10
MA - Marocco 10
JO - Giordania 9
NP - Nepal 8
KR - Corea 7
RO - Romania 7
TN - Tunisia 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PE - Perù 6
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AT - Austria 4
CH - Svizzera 4
EG - Egitto 4
KG - Kirghizistan 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
CR - Costa Rica 3
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GM - Gambi 1
GY - Guiana 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 17.335
Città #
Singapore 1.100
Ashburn 1.021
Woodbridge 897
Fairfield 876
Houston 585
Jacksonville 565
San Jose 549
Ann Arbor 502
Chandler 433
Santa Clara 408
Hong Kong 405
Beijing 390
Seattle 337
Wilmington 310
Dallas 304
Cambridge 252
Izmir 174
Nanjing 170
Ho Chi Minh City 163
Warsaw 158
Dearborn 127
Los Angeles 125
Hanoi 121
Princeton 107
San Diego 104
Lauterbourg 90
Tokyo 90
New York 83
Boardman 74
Council Bluffs 71
Addison 68
São Paulo 67
Mexico City 58
Milan 55
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Shanghai 38
Brooklyn 37
Ferrara 37
Hebei 35
Brussels 34
Helsinki 30
Jiaxing 29
London 29
Washington 28
Chicago 27
Da Nang 27
Tianjin 27
Jinan 23
Phoenix 23
San Mateo 23
Buffalo 22
Falkenstein 22
San Francisco 22
Auburn Hills 21
Porto Alegre 21
Rio de Janeiro 21
Toronto 21
Turku 21
Bremen 19
Changsha 19
Haiphong 19
Orem 19
Baghdad 18
Frankfurt am Main 18
Johannesburg 18
Kunming 18
Mountain View 16
Zhengzhou 16
Boston 15
Chennai 15
Jakarta 15
Montreal 15
Moscow 15
Stockholm 15
Manchester 14
Philadelphia 13
Poplar 13
Tashkent 13
Denver 12
Falls Church 12
Guangzhou 12
Norwalk 12
Atlanta 11
Ningbo 11
Amsterdam 10
Belo Horizonte 10
Brasília 10
Columbus 10
Dong Ket 10
Hải Dương 10
The Dalles 10
Des Moines 9
Indiana 9
Redwood City 9
Augusta 8
Bogotá 8
Dhaka 8
Totale 12.158
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 412
A cyclic peptide T analogue with high chemotactic activity 288
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 263
Arecoline tripeptide inhibitors of proteasome 252
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 248
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 227
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 226
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 222
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 220
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 217
Vinyl ester-based cyclic peptide proteasome inhibitors 216
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 216
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 210
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 209
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 208
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 207
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 206
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 206
A Bioactive Fullerene Peptide 202
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 200
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 200
A 500 MHz study of peptide T in a DMSO solution 200
Conformational analysis of peptide T and of its C‐pentapeptide fragment 196
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 195
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 193
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 193
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 190
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 189
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 187
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 187
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 184
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 182
Structure–activity relationships of cyclic and linear peptide T analogues 181
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 178
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 178
Synthesis and biological activity of carboxyl terminally extended dermorphins 175
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 173
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 173
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 173
Anodic mineralization of pentachlorophenol in alkaline media 173
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 172
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 167
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 166
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 163
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 162
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 159
Conformational properties of deltorphin: new features of the delta-opioid receptors 158
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 158
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 157
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 157
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 157
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 156
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 155
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 154
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 153
New cyclic peptide proteasome inhibitors 152
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 151
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 151
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 151
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 146
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 144
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 144
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 144
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 144
Synthesis and structure activity relationships of delthorphine analogues 143
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 141
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 140
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 138
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 133
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 133
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 131
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 131
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 129
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 129
Opioid peptides. Partially modified retro-inverso dermorphin analogues 129
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 129
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 127
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 127
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 127
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 126
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 123
Synthesis and activity of new linear and cyclic peptide T derivatives 122
Synthesis and biological activity of chelator-peptide T conjugates 120
Peptide-based molecules for the production of positive charged liposomes and micelles 119
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 118
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 118
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 117
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 115
Structure-activity relationships of peptide T-related pentapeptides 112
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 112
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TO PENTAPEPTIDE ANALOG DERIVED FROM IMMUNODEFICIENCY VIRUS PROTEIN gp120 109
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 108
null 107
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 107
null 107
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 105
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 101
Synthesis and antiaggregatory activity of antiflammin related peptides 99
null 96
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 95
Totale 16.399
Categoria #
all - tutte 76.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.289
Totale 77.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.267 44 91 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20265.986 652 290 733 745 772 363 649 278 537 708 191 68
2026/2027183 183 0 0 0 0 0 0 0 0 0 0 0
Totale 17.454